Good News! EClinCloud Named to the Zhejiang Seed Unicorn Enterprises Top 100

Recently, EClinCloud, as a representative enterprise in next-generation information technology, was selected for the Zhejiang Seed Unicorn Enterprises Top 100 list.
Selections for this list were conducted across Zhejiang Province to identify high-performing enterprises with high growth and innovation potential; the selected companies generally feature strong technology-driven capabilities, notable innovation capacity, and broad market prospects. This selection represents dual recognition of EClinCloud's innovation strength and development potential.
Since officially relocating its corporate headquarters to Ningbo, Zhejiang in September 2024, EClinCloud has been rapidly unleashing its innovation vitality and development momentum.
In March 2025, amid a capital winter, the company completed a new funding round of tens of millions of yuan to accelerate the R&D and deployment of AI technologies and speed up its global strategic expansion;
In April 2025, the digital solution for innovative drug clinical research won first prize in the "AI Ningbo" competition, receiving fund investment and talent policy support;
In June 2025, the headquarters office base in Ningbo Qianwan New Area is set to be established, marking a comprehensive upgrade of the company's presence in the Yangtze River Delta;
Meanwhile, EClinCloud is continuing to expand talent recruitment in AI, building an integrated innovation team that combines technology, products, and services.
Moving forward steadily on the path of innovation, EClinCloud will take Ningbo as a new starting point to continue deepening its work in
"AI + clinical R&D," advance talent acquisition and technological innovation, accelerate its global expansion, and comprehensively empower clinical research to improve quality and efficiency.


